{
    "clinical_study": {
        "@rank": "41835", 
        "arm_group": [
            {
                "arm_group_label": "Valves plus cells", 
                "arm_group_type": "Active Comparator", 
                "description": "Bronchoscopy Five patients will be selected to receive bone-marrow derived mesenchymal stromal cells delivered bronchoscopically right before insertion of one-way endobronchial valves."
            }, 
            {
                "arm_group_label": "Valves plus saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Bronchoscopy Five patients will be selected for treatment with one-way endobronchial valves only, with saline injected prior to valve insertion."
            }
        ], 
        "brief_summary": {
            "textblock": "The combined use of one-way endobronchial valves and bone-marrow derived mesenchymal stromal\n      cells in patients with severe pulmonary emphysema is safe and will contribute to increase\n      quality of life."
        }, 
        "brief_title": "Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pulmonary Emphysema", 
        "condition_browse": {
            "mesh_term": [
                "Emphysema", 
                "Pulmonary Emphysema"
            ]
        }, 
        "detailed_description": {
            "textblock": "In addition to testing the safety of one-way endobronchial valves combined with bone-marrow\n      derived mesenchymal stromal cells, the study will determine the systemic inflammatory\n      potential of cell therapy measured by C-reactive protein levels (CRP), erythrocyte\n      sedimentation rate (ESR) and complete blood count in peripheral blood. Finally, the study\n      will aim at determining if other markers of inflammatory response and remodeling are\n      modulated by this therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of severe heterogeneous emphysema (heterogeneity > 15%), with heterogeneity\n             defined as the difference between lobes in the percent area covered by parenchymal\n             density greater than -950 Hounsfield Units.\n\n          -  Estimation of collateral ventilation based on fissure with integrity \u2265 75%.\n\n          -  Total lung capacity> 100% predicted.\n\n          -  Residual volume> 150% predicted.\n\n          -  Forced expiratory volume at the first minute <45% predicted.\n\n          -  Diffusing capacity of the lungs for carbon monoxide <45% predicted.\n\n          -  Optimal medical treatment.\n\n          -  Limitations in daily physical activities.\n\n          -  Minimum of 4 months without smoking\n\n          -  Having family support.\n\n          -  Stage \u2265 2 in modified Medical Research Council Dyspnea Scale  (MMRC).\n\n        Exclusion Criteria:\n\n          -  Homogenous emphysema.\n\n          -  Presence of collateral ventilation.\n\n          -  Use of systemic corticosteroids (prednisone> 20mg/day or equivalent).\n\n          -  Pulmonary or extrapulmonary infection.\n\n          -  Coronary heart disease and/or severe ventricular dysfunction.\n\n          -  Significant renal or liver disease.\n\n          -  Immunosuppressive disease.\n\n          -  Active smoking.\n\n          -  Cancer prognosis with survival <2 years.\n\n          -  Psychosocial problems.\n\n          -  Pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01872624", 
            "org_study_id": "13-0150"
        }, 
        "intervention": {
            "arm_group_label": [
                "Valves plus cells", 
                "Valves plus saline"
            ], 
            "description": "Bronchoscopic delivery of one-way valves and bone-marrow derived mesenchymal stromal cells.", 
            "intervention_name": "Bronchoscopy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "June 5, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Curitiba", 
                        "country": "Brazil", 
                        "state": "PR", 
                        "zip": "80215-901"
                    }, 
                    "name": "Pontificia Universidade Catolica do Parana"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de Janeiro", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "21941-902"
                    }, 
                    "name": "Universidade Federal do Rio de Janeiro"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "hugo@oliveira.com", 
                    "last_name": "Hugo G Oliveira, PhD", 
                    "phone": "555198658151"
                }, 
                "contact_backup": {
                    "email": "fsvartman@hotmail.com", 
                    "last_name": "Fabio M Svartman, MD", 
                    "phone": "555192492231"
                }, 
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90035-003"
                    }, 
                    "name": "Hospital de Cl\u00ednicas de Porto Alegre"
                }, 
                "investigator": [
                    {
                        "last_name": "Hugo G Oliveira, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Fabio M Svartman, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Amarilio V Macedo-Neto, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Bone-marrow Derived Mesenchymal Stromal Cells Associated With One-way Endobronchial Valves in Patients With Pulmonary Emphysema: Safety Study", 
        "overall_contact": {
            "email": "hugo@oliveira.com", 
            "last_name": "Hugo G Oliveira, MD, PhD", 
            "phone": "+55-52-9865.8151"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital de Cl\u00ednicas de Porto Alegre", 
                "last_name": "Hugo G Oliveira, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universidade Federal do Rio de Janeiro", 
                "last_name": "Patricia RM Rocco, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Absence of lung deficits during the procedure and/or in the 4 months follow-up", 
            "safety_issue": "Yes", 
            "time_frame": "4 months"
        }, 
        "reference": [
            {
                "PMID": "21656291", 
                "citation": "Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PR. Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med. 2011 Sep;37(9):1421-31. doi: 10.1007/s00134-011-2268-3. Epub 2011 Jun 9. Review."
            }, 
            {
                "PMID": "16840401", 
                "citation": "de Oliveira HG, Macedo-Neto AV, John AB, Jungblut S, Prolla JC, Menna-Barreto SS, Fortis EA. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest. 2006 Jul;130(1):190-9."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01872624"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital de Clinicas de Porto Alegre", 
            "investigator_full_name": "Hugo Goulart de Oliveira", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "St. George Respiratory Questionnaire", 
                "measure": "Quality of Life", 
                "safety_issue": "Yes", 
                "time_frame": "120 days"
            }, 
            {
                "description": "Spirometry, flow-volume curve, post-bronchodilator test, determination of residual volume, airway resistance by plethysmography, diffusing capacity of the lung for carbon monoxide, and six-minute walk test", 
                "measure": "Pulmonary function", 
                "safety_issue": "Yes", 
                "time_frame": "120 days"
            }, 
            {
                "description": "Collection of blood samples for determination of C-reactive protein (CRP), erythrocyte", 
                "measure": "Inflammation", 
                "safety_issue": "Yes", 
                "time_frame": "120 days"
            }
        ], 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ministry of Health, Brazil", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Research Council, Brazil", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Rio de Janeiro State Research Supporting Foundation (FAPERJ)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universidade Federal do Rio de Janeiro", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Hospital de Clinicas de Porto Alegre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}